中商官网
研究报告
长江生命科技（HK0775）
| 科目\年度 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 税后利润 |
-12655.40 | 1725.00 | 13195.20 | 16280.10 | 12522.80 | 18996.10 | 30068.90 | 28054.50 | 26721.50 | 18612.80 | 27275.20 | 23454.60 | 19803.40 |
| 营业收入 |
552267.40 | 532273.30 | 527559.00 | 540231.20 | 494254.40 | 496702.40 | 523299.20 | 469313.30 | 486854.00 | 491930.90 | 495404.30 | 497092.70 | 454502.20 |
| 销售成本 |
383011.90 | 368552.50 | 364960.40 | 377234.20 | 353563.80 | 336028.70 | 349862.80 | 314932.20 | 320604.20 | 317746.20 | 321372.10 | 322911.30 | 299221.60 |
| 税前利润 |
-9148.20 | 6858.40 | 20486.40 | 23823.90 | 11912.60 | 21743.50 | 42122.60 | 32999.30 | 36216.10 | 24958.10 | 32113.00 | 30372.90 | 30101.30 |
| 归属于母公司股东利润 |
-12655.40 | 1725.00 | 13196.30 | 16280.10 | 12523.40 | 18173.50 | 26300.10 | 25840.20 | 25296.00 | 21885.70 | 26355.80 | 22900.80 | 17633.10 |
| 营业收入 |
552267.40 | 532273.30 | 527559.00 | 540231.20 | 494254.40 | 496702.40 | 523299.20 | 469313.30 | 486854.00 | 491930.90 | 495404.30 | 497092.70 | 454502.20 |
| 其中：营业额 |
552267.40 | 532273.30 | 527559.00 | 540231.20 | 494254.40 | 496702.40 | 523299.20 | 469313.30 | 486854.00 | 491930.90 | 495404.30 | 497092.70 | 454502.20 |
| 销售成本 |
383011.90 | 368552.50 | 364960.40 | 377234.20 | 353563.80 | 336028.70 | 349862.80 | 314932.20 | 320604.20 | 317746.20 | 321372.10 | 322911.30 | 299221.60 |
| 毛利 |
169255.50 | 163720.80 | 162598.60 | 162997.00 | 140690.60 | 160673.70 | 173436.40 | 154381.10 | 166249.80 | 174184.70 | 174032.20 | 174181.40 | 155280.60 |
| 加：其他收入 |
27368.80 | 13463.70 | 8129.40 | 2683.90 | 3879.90 | -2452.80 | -89.10 | 3734.70 | 2810.20 | 11406.00 | -2742.40 | 3966.60 | -1288.20 |
| 管理费用 |
74711.09 | 68950.09 | 63813.30 | 68585.20 | 64779.30 | 65004.20 | 58460.50 | 58666.20 | 59200.90 | 58127.40 | 56503.89 | 56020.80 | 50804.40 |
| 财务费用 |
33718.40 | 32242.50 | 16309.20 | 9782.30 | 12872.60 | 15888.40 | 12967.40 | 9422.70 | 9585.80 | 10488.90 | 10956.60 | 10395.30 | 8862.30 |
| 其他费用 |
86798.00 | 72385.90 | 74793.20 | 70750.59 | 67436.00 | 67724.60 | 76703.00 | 80550.20 | 75345.40 | 88189.60 | 86485.00 | 86062.20 | 64628.40 |
| 加：投资物业公允价值变动 |
-10559.80 | 3219.10 | 4671.70 | 7140.60 | 12282.00 | 12038.50 | 16759.10 | 18101.30 | 6992.80 | -8648.80 | 9176.50 | 304.10 | 652.10 |
| 经营溢利 |
-9163.00 | 6825.10 | 20484.00 | 23703.40 | 11764.60 | 21642.20 | 41975.50 | 27578.00 | 31920.70 | 20136.00 | 26520.80 | 25973.80 | 30349.40 |
| 应占共同控制实体业绩 |
14.80 | 33.30 | 2.40 | 120.50 | 148.00 | 101.30 | 147.10 | 5421.30 | 4295.40 | 4822.10 | -- | -- | -- |
| 税前利润特殊科目 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5592.20 | 4399.10 | -248.10 |
| 税前利润 |
-9148.20 | 6858.40 | 20486.40 | 23823.90 | 11912.60 | 21743.50 | 42122.60 | 32999.30 | 36216.10 | 24958.10 | 32113.00 | 30372.90 | 30101.30 |
| 减：所得税费用 |
3507.20 | 5133.40 | 7291.20 | 7543.80 | -610.20 | 2747.40 | 12053.70 | 4944.80 | 9494.60 | 6345.30 | 4837.80 | 6918.30 | 10297.90 |
| 税后利润 |
-12655.40 | 1725.00 | 13195.20 | 16280.10 | 12522.80 | 18996.10 | 30068.90 | 28054.50 | 26721.50 | 18612.80 | 27275.20 | 23454.60 | 19803.40 |
| 归属于母公司股东利润 |
-12655.40 | 1725.00 | 13196.30 | 16280.10 | 12523.40 | 18173.50 | 26300.10 | 25840.20 | 25296.00 | 21885.70 | 26355.80 | 22900.80 | 17633.10 |
| 归属于非控制股股东利润 |
-- | -- | -1.10 | -- | -0.60 | 822.60 | 3768.80 | 2214.30 | 1425.50 | -3272.90 | 919.40 | 553.80 | 2170.30 |
| 基本每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 稀释每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 其他综合收益 |
-55115.10 | 9190.40 | -38123.50 | -28430.50 | 51937.30 | -13569.00 | -43661.80 | 22104.70 | 3881.80 | -69785.60 | -38904.60 | -65664.90 | 8428.60 |
| 综合收益总额 |
-67770.50 | 10915.40 | -24928.30 | -12150.40 | 64460.10 | 5427.10 | -13592.90 | 50159.20 | 30603.30 | -51172.80 | -11629.40 | -42210.30 | 28232.00 |
| 归属于母公司股东综合收益总额 |
-67770.50 | 10915.40 | -24927.20 | -12150.40 | 64460.70 | 5090.70 | -16247.30 | 47436.30 | 28948.40 | -45774.30 | -11086.00 | -40364.00 | 25431.70 |
| 归属于非控制股股东综合收益总额 |
-- | -- | -1.10 | -- | -0.60 | 336.40 | 2654.40 | 2722.90 | 1654.90 | -5398.50 | -543.40 | -1846.30 | 2800.30 |